Cargando…

“Prediction Is Very Hard, Especially About the Future”: New Biomarkers for Type 2 Diabetes?

Detalles Bibliográficos
Autores principales:	Lowe, William L., Bain, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636630/ https://www.ncbi.nlm.nih.gov/pubmed/23613559 http://dx.doi.org/10.2337/db13-0057

Ejemplares similares

Prediction is very difficult, especially about the future
por: Tomšič, Anton, et al.
Publicado: (2021)

Antimicrobial Drug Resistance: "Prediction Is Very Difficult, Especially about the Future"
por: Courvalin, Patrice
Publicado: (2005)

Commentary: Nomograms—or as Yogi Berra said, “It's tough to make predictions, especially about the future”
por: Inra, Matthew L., et al.
Publicado: (2021)

Genetic-based prediction of disease traits: prediction is very difficult, especially about the future(†)
por: Schrodi, Steven J., et al.
Publicado: (2014)

Hard truths about preoperative knee X-rays
por: Mak, Wai-Keong, et al.
Publicado: (2020)

Inflammation, Insulin Resistance, and Type 2 Diabetes: Back to the Future?
por: Cefalu, William T.
Publicado: (2009)

The contribution of the environment (especially diet) to breast cancer risk
por: Michels, Karin B
Publicado: (2002)

Would you like to be contacted about future research?
por: Newington, Lisa, et al.
Publicado: (2021)

An old drug as a promising new cure for the hard-to-treat echinococcosis
por: Zhu, Guan, et al.
Publicado: (2020)

Targeted Metabolomics Finds Its Mark in Diabetes Research
por: Bain, James R.
Publicado: (2013)

Prediction of Type 1 Diabetes
por: Erlich, Henry A., et al.
Publicado: (2013)

Emergence of a Predictive Clinical Biomarker for Diabetic Neuropathy
por: Kiernan, Matthew C.
Publicado: (2012)

Three stories about the conduct of science: Past, future, and present
por: Neylon, Cameron
Publicado: (2011)

One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2021)

Do multiparous women need to work or exercise extra hard to control gestational diabetes?
por: Matikainen, Niina, et al.
Publicado: (2022)

Status of Diabetes Care: New Challenges, New Concepts, New Measures—Focusing on the Future!
por: Cefalu, William T., et al.
Publicado: (2015)

Frailty, anemia and potential future biomarkers
por: Kapsokoulou, Athina, et al.
Publicado: (2019)

Clobazam: The phoenix drug (from the very old to the brand new)
por: Guerreiro, Carlos A. M.
Publicado: (2014)

A brief analysis and hypotheses about the risk of COVID-19 for people with type 1 and type 2 diabetes mellitus
por: Milionis, Charalampos, et al.
Publicado: (2020)

A holistic approach to predicting diabetes risk via biomarkers
por: Cohen, Alan A.
Publicado: (2021)

Let’s talk about mucormycosis emergency with COVID-19: Invest in future
por: Malik, Kamlesh, et al.
Publicado: (2022)

Exposure to Toxicants Affects Everyone, Especially the Very Young
por: Abbott, Louise C.
Publicado: (2022)

Risk scores in anaesthesia: the future is hard to predict
por: Drayton, Daniel James, et al.
Publicado: (2022)

Pancreatic islet transplantation in type 1 diabetes: Current state and future perspectives
por: Kuo, Chun‐Heng, et al.
Publicado: (2022)

Is Estradiol a Biomarker of Type 2 Diabetes Risk in Postmenopausal Women?
por: Mauvais-Jarvis, Franck
Publicado: (2017)

Predicting outcome in patients with sepsis: new biomarkers for old expectations
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2014)

Commentary: Managing rock hard cataracts
por: Thakur, Anchal, et al.
Publicado: (2022)

Public health physicians: who are they and why we need more of them – especially in Victoria
por: Wilson, Alyce N., et al.
Publicado: (2021)

A new era of diagnostic modalities for type 1 leprosy reactions: Promise for the future
por: Thomas, Mary
Publicado: (2015)

Delirium in the ICU: time to probe the hard questions
por: Stevens, Robert D, et al.
Publicado: (2011)

The Benefits and Risks of New Therapies for Type 2 Diabetes
por: Asche, Car V., et al.
Publicado: (2008)

It’s hard to reach the “hard-to-reach”: the challenges of recruiting people who do not access preventative healthcare services into interview studies
por: Rockliffe, Lauren, et al.
Publicado: (2018)

AKI patients have worse long-term outcomes, especially in the immediate post-ICU period
por: Hoste, Eric AJ, et al.
Publicado: (2012)

What can chronic arthritis pain teach about developing new analgesic drugs?
por: Witter, James, et al.
Publicado: (2004)

Is Very Low Always Useful? The Case of Very Low-Grade Albuminuria in Kidney Disease
por: Cohen, Eric P., et al.
Publicado: (2018)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

COVID-19 vaccinations in The Gambia: efforts, challenges, and future directions
por: Lowe, Mat, et al.
Publicado: (2022)

The very hungry bactericidal antibiotics
por: Rasouly, Aviram, et al.
Publicado: (2022)

Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently)
por: Maggi, Davide, et al.
Publicado: (2019)

Functional MRI Signal Fluctuations: A Preclinical Biomarker for Cognitive Impairment in Type 2 Diabetes?
por: Belfort-DeAguiar, Renata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hp2tq74mhgf6fgpo22vsilntkn